This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Eton Pharmaceuticals’s 8K filing here.
About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.
Read More
- Five stocks we like better than Eton Pharmaceuticals
- What Are Trending Stocks? Trending Stocks Explained
- 3 S&P 500 Stocks With Sky High Risk-Adjusted Returns
- Stock Market Upgrades: What Are They?
- Trending Stocks: How to Spot, Trade, and Profit Safely
- Stock Sentiment Analysis: How it Works
- Roku’s Recovery Prospects: Why 2025 Could Be a Game-Changer
